198 related articles for article (PubMed ID: 33958615)
21. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase.
Wössmann W; Schrappe M; Meyer U; Zimmermann M; Reiter A
Ann Hematol; 2003 Mar; 82(3):160-5. PubMed ID: 12634948
[TBL] [Abstract][Full Text] [Related]
22. Benefit of continuous kidney replacement therapy for managing tumor lysis syndrome in children with hematologic malignancies.
Anderson A; Shoulders L; James V; Ashcraft E; Cheng C; Ribeiro R; Elbahlawan L
Front Oncol; 2023; 13():1234677. PubMed ID: 37664024
[TBL] [Abstract][Full Text] [Related]
23. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
Cheuk DK; Chiang AK; Chan GC; Ha SY
Cochrane Database Syst Rev; 2014 Aug; (8):CD006945. PubMed ID: 25121561
[TBL] [Abstract][Full Text] [Related]
24. Determining relative importance of variables in developing and validating predictive models.
Beyene J; Atenafu EG; Hamid JS; To T; Sung L
BMC Med Res Methodol; 2009 Sep; 9():64. PubMed ID: 19751506
[TBL] [Abstract][Full Text] [Related]
25. Clinical Profile and Short-Term Outcome of Pediatric Hyperleukocytic Acute Leukemia from a Developing Country.
Baqari SAS; Haque A; Ashraf MS; Alam MM; Fadoo Z
J Coll Physicians Surg Pak; 2017 Jul; 27(7):450-454. PubMed ID: 28818172
[TBL] [Abstract][Full Text] [Related]
26. Rasburicase for the management of tumor lysis syndrome in neonates.
McNutt DM; Holdsworth MT; Wong C; Hanrahan JD; Winter SS
Ann Pharmacother; 2006; 40(7-8):1445-50. PubMed ID: 16868218
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol.
Blum KA; Ruppert AS; Woyach JA; Jones JA; Andritsos L; Flynn JM; Rovin B; Villalona-Calero M; Ji J; Phelps M; Johnson AJ; Grever MR; Byrd JC
Leukemia; 2011 Sep; 25(9):1444-51. PubMed ID: 21606960
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome.
Jeon YW; Kwak DH; Park SS; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):595-603. PubMed ID: 28711571
[TBL] [Abstract][Full Text] [Related]
29. Onco-nephrology: tumor lysis syndrome.
Wilson FP; Berns JS
Clin J Am Soc Nephrol; 2012 Oct; 7(10):1730-9. PubMed ID: 22879434
[TBL] [Abstract][Full Text] [Related]
30. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Baeksgaard L; Sørensen JB
Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
[TBL] [Abstract][Full Text] [Related]
31. [Tumor lysis syndrome].
Hagino T
Gan To Kagaku Ryoho; 2010 Jun; 37(6):984-8. PubMed ID: 20567098
[TBL] [Abstract][Full Text] [Related]
32. Management of pediatric tumor lysis syndrome.
Tazi I; Nafl H; Elhoudzi J; Mahmal L; Harif M
Arab J Nephrol Transplant; 2011 Sep; 4(3):147-54. PubMed ID: 22026339
[TBL] [Abstract][Full Text] [Related]
33. Tumour lysis syndrome in children: experience of last decade.
Ahn YH; Kang HJ; Shin HY; Ahn HS; Choi Y; Kang HG
Hematol Oncol; 2011 Dec; 29(4):196-201. PubMed ID: 21710502
[TBL] [Abstract][Full Text] [Related]
34. A review of clinical and laboratory findings and treatment of tumor lysis syndrome.
Yarpuzlu AA
Clin Chim Acta; 2003 Jul; 333(1):13-8. PubMed ID: 12809731
[TBL] [Abstract][Full Text] [Related]
35. [Metabolic disorders in the treatment of malignant hematologic diseases--the acute tumor lysis syndrome].
Nielsen SH; Hasselbalch HC; Birgens HS
Ugeskr Laeger; 1991 Oct; 153(42):2952-3. PubMed ID: 1949322
[TBL] [Abstract][Full Text] [Related]
36. Intracranial Hemorrhage in Childhood Acute Leukemia: Incidence, Characteristics, and Contributing Factors.
Intusoma U; Nakorn CN; Chotsampancharoen T
Pediatr Neurol; 2019 Oct; 99():23-30. PubMed ID: 31326259
[TBL] [Abstract][Full Text] [Related]
37. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma.
Hande KR; Garrow GC
Am J Med; 1993 Feb; 94(2):133-9. PubMed ID: 8430709
[TBL] [Abstract][Full Text] [Related]
38. Tumor lysis syndrome in small cell carcinoma and other solid tumors.
Kalemkerian GP; Darwish B; Varterasian ML
Am J Med; 1997 Nov; 103(5):363-7. PubMed ID: 9375703
[TBL] [Abstract][Full Text] [Related]
39. Managing tumor lysis syndrome.
Greguska C
JAAPA; 2021 Jan; 34(1):10-13. PubMed ID: 33315730
[TBL] [Abstract][Full Text] [Related]
40. Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia.
Cheson BD; Frame JN; Vena D; Quashu N; Sorensen JM
J Clin Oncol; 1998 Jul; 16(7):2313-20. PubMed ID: 9667245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
